Status:
ACTIVE_NOT_RECRUITING
Longitudinal Identity Study of Childhood Cancer Survivors
Lead Sponsor:
KU Leuven
Collaborating Sponsors:
Research Foundation Flanders
Universitaire Ziekenhuizen KU Leuven
Conditions:
Pediatric Cancer
Eligibility:
All Genders
14-25 years
Brief Summary
The study investigators plan to conduct a longitudinal questionnaire study in adolescents and emerging adults (14-25 years of age at the start of the study) who survived childhood cancer to chart thei...
Detailed Description
In the present longitudinal study, four main research questions will be investigated. 1. How does identity develop in cancer survivors? Based on previous findings from studies in identity development...
Eligibility Criteria
Inclusion
- Survivors of childhood leukemia/lymphoma, solid tumors, and brain tumors, of whom the treatment has ended.
- 14-25 years at the start of the study
- Treated at the department of pediatric oncology at University Hospital Leuven, Belgium.
- Sufficient knowledge of Dutch
Exclusion
- Mental retardation which hinders completion of the questionnaire bundle
- Younger than 14 year and older than 25 year
- Physically incapable to complete the questionnaire bundle
- Insufficient knowledge of Dutch
- Contact information is not available
Key Trial Info
Start Date :
August 28 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2024
Estimated Enrollment :
126 Patients enrolled
Trial Details
Trial ID
NCT03424343
Start Date
August 28 2018
End Date
December 1 2024
Last Update
August 21 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gasthuisberg
Leuven, Vlaams-Brabant, Belgium, 3000